Abstract
Background: Benign prostatic hyperplasia (BPH), the most common condition in aging men is the non cancerous proliferation of epithelial and stromal cells of the prostate gland and is associated with lower urinary tract symptoms (LUTS) such as frequency hesitancy urgency etc. Sources of symptoms in patient with BPH appear to be both static and dynamic component. Better understanding of the prostate physiology, function and pathogenesis has lead to the development of promising agents, useful in the management of lower urinary tract symptoms in men.
Objective: Treatment of clinical BPH aims to improve symptoms, prevent urinary tract infections, avoid renal insult, relief obstruction and improve bladder emptying. Many herbal formulations, or plant derived non-nutritive compounds with protective or disease preventive properties are getting popularized worldwide for the management of BPH, especially due to long term side effects of pharmacological treatment and risk of mortality associated with surgical procedures. Phytotherapeutic preparations are plant extracts with different components obtained by different extraction procedures. Numerous mechanisms of action have been postulated for mono and combination plant extracts. Conclusion: This article give a brief account of rationale and efficacy of various existing phytotherapeutic agents in the management of benign prostatic hyperplasia, including the herbs which hold the potential promise are also mentioned, although much research is still required.Keywords: Benign prostatic hyperplasia management, dihydrotestosterone, enlarged prostate, herbal remedies, phytotherapy, testosterone.
Mini-Reviews in Medicinal Chemistry
Title:Phytotherapeutic Agents for Benign Prostatic Hyperplasia: An Overview
Volume: 17 Issue: 14
Author(s): Meenakshi Sharma, Renu Chadha and Neelima Dhingra*
Affiliation:
- University Institute of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, Panjab University, Chandigarh-160014,India
Keywords: Benign prostatic hyperplasia management, dihydrotestosterone, enlarged prostate, herbal remedies, phytotherapy, testosterone.
Abstract: Background: Benign prostatic hyperplasia (BPH), the most common condition in aging men is the non cancerous proliferation of epithelial and stromal cells of the prostate gland and is associated with lower urinary tract symptoms (LUTS) such as frequency hesitancy urgency etc. Sources of symptoms in patient with BPH appear to be both static and dynamic component. Better understanding of the prostate physiology, function and pathogenesis has lead to the development of promising agents, useful in the management of lower urinary tract symptoms in men.
Objective: Treatment of clinical BPH aims to improve symptoms, prevent urinary tract infections, avoid renal insult, relief obstruction and improve bladder emptying. Many herbal formulations, or plant derived non-nutritive compounds with protective or disease preventive properties are getting popularized worldwide for the management of BPH, especially due to long term side effects of pharmacological treatment and risk of mortality associated with surgical procedures. Phytotherapeutic preparations are plant extracts with different components obtained by different extraction procedures. Numerous mechanisms of action have been postulated for mono and combination plant extracts. Conclusion: This article give a brief account of rationale and efficacy of various existing phytotherapeutic agents in the management of benign prostatic hyperplasia, including the herbs which hold the potential promise are also mentioned, although much research is still required.Export Options
About this article
Cite this article as:
Sharma Meenakshi , Chadha Renu and Dhingra Neelima*, Phytotherapeutic Agents for Benign Prostatic Hyperplasia: An Overview, Mini-Reviews in Medicinal Chemistry 2017; 17 (14) . https://dx.doi.org/10.2174/1389557516666160621103817
DOI https://dx.doi.org/10.2174/1389557516666160621103817 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Mitochondria as a Therapeutic Target in Metabolic Disorders
Mitochondria are the primary site of adenosine triphosphate (ATP) production in mammalian cells. Moreover, these organelles are an important source of reactive oxygen and nitrogen species in virtually any nucleated cell type. The modulation of a myriad of cellular signaling pathways depends on the mitochondrial physiology. Mitochondrial dysfunction is observed ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer?s, Parkinson?s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
DNA Methyltransferase Inhibitors and their Therapeutic Potential
Current Topics in Medicinal Chemistry 2', 4'-dihydroxy-3, 4-methylenedioxychalcone Activate Mitochondrial Apoptosis of Ehrlich Ascites Carcinoma Cells
Current Drug Therapy Synthetic and Natural Coumarins as Cytotoxic Agents
Current Medicinal Chemistry - Anti-Cancer Agents Antigonadotropins: A Novel Strategy to Halt Alzheimers Disease Progression
Current Pharmaceutical Design Trefoil Factor Family (TFF) Peptides and their Different Roles in the Mucosal Innate Immune Defense and More: An Update
Current Medicinal Chemistry Role of MicroRNAs in Treatment Response in Prostate Cancer
Current Cancer Drug Targets Design, Synthesis and Antiproliferative Activity of Novel Benzothiazole Derivatives Conjugated with Semicarbazone Scaffold
Medicinal Chemistry Nutritional Modulation of Terminal End Buds: Its Relevance to Breast Cancer Prevention
Current Cancer Drug Targets BRCA Unclassified Variants: How Can They be Classified?
Current Women`s Health Reviews Collaborative and Defensive Fibroblasts in Tumor Progression and Therapy Resistance
Current Medicinal Chemistry AAV-Mediated Gene Supply for Treatment of Degenerative and Neovascular Retinal Diseases
Current Gene Therapy Antifungal Drug Discovery through the Study of Invertebrate Model Hosts
Current Medicinal Chemistry Aspartic Proteases in Drug Discovery
Current Pharmaceutical Design Versatile Functions of Heat Shock Factors: It is Not All About Stress
Current Immunology Reviews (Discontinued) Control of Interleukin-1β Secretion in Inflammation and Immune Response
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Plastid Molecular Pharming II. Production of Biopharmaceuticals by Plastid Transformation
Mini-Reviews in Medicinal Chemistry To Cardiovascular Disease and Beyond: New Therapeutic Perspectives of Statins in Autoimmune Diseases and Cancer
Current Drug Targets Polymer Nanoparticles - A Novel Strategy for Administration of Paclitaxel in Cancer Chemotherapy
Current Medicinal Chemistry Biotransformation of Silybin and its Congeners
Current Drug Metabolism The Weal and Woe of Costimulation in the Adoptive Therapy of Cancer with Chimeric Antigen Receptor (CAR)-Redirected T Cells
Current Molecular Medicine